Robert Chitren

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells”.

Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells

Frontiers in Pharmacology(2022)10.3389/fphar.2022.894535

N/A

0DataRank · unranked

9 citations

Omar S. Al‐Odat, Robert Chitren, J Singh, Sandeep Kumar Srivastava, Krishne Gowda +7 more

Development of a Novel Bruton’s Tyrosine Kinase Inhibitor that exerts Anti-Cancer Activities Potentiates Response of Chemotherapeutic Agents In Multiple Myeloma Stem Cell-Like Cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.10.483708

N/A

0DataRank · unranked

0 citations

Omar S. Al‐Odat, Robert Chitren, J Singh, Sandeep Kumar Srivastava, Krishne Gowda +6 more